One year in review 2016: novelties in the treatment of rheumatoid arthritis

Clin Exp Rheumatol. 2016 May-Jun;34(3):357-72. Epub 2016 May 30.

Abstract

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / pharmacology*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / physiopathology
  • Arthritis, Rheumatoid / psychology
  • Biological Therapy / methods*
  • Clinical Trials as Topic
  • Humans
  • Medication Therapy Management / trends
  • Patient Selection
  • Quality of Life*
  • Therapies, Investigational
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha